Fund Holdings — First Turn Management, LLC

Total Portfolio Value:
$665.99M
Total Bought:
$286.54M
Total Sold:
$183.86M
Net Transaction:
+$102.67M
Notable People:
Lisa Gable Wheatley, Tracy Austin Murphy, Stephen Allyn Rosetta
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)372,672319,773-52,899$37.51M$46.05M6.91%+$8.54M
Mirum Pharmaceuticals, Inc.(MIRM)527,540570,569+43,029$26.85M$41.83M6.28%+$14.98M
United Therapeutics Corporation(UTHR)085,318+85,318$0$35.77M5.37%+$35.77M
Merus N V292,964372,022+79,058$15.41M$35.03M5.26%+$19.62M
Nuvalent Inc320,798394,754+73,956$24.48M$34.14M5.13%+$9.66M
Xenon Pharmaceuticals Inc.(XENE)660,617799,743+139,126$20.68M$32.11M4.82%+$11.43M
BridgeBio Pharma, Inc.(BBIO)551,684589,729+38,045$23.82M$30.63M4.60%+$6.81M
Revolution Medicines, Inc.(RVMD)415,591643,050+227,459$15.29M$30.03M4.51%+$14.74M
Ascendis Pharma A/SADR(ASND)134,687146,291+11,604$23.25M$29.08M4.37%+$5.84M
argenx SEADR(ARGX)43,95338,767-5,186$24.23M$28.59M4.29%+$4.37M
Disc Medicine, Inc.(IRON)299,464397,693+98,229$15.86M$26.28M3.95%+$10.42M
ORIC Pharmaceuticals, Inc.(ORIC)2,009,9232,159,474+149,551$20.40M$25.91M3.89%+$5.51M
Arcellx Inc
COMMON STOCK
215,223313,733+98,510$14.17M$25.76M3.87%+$11.59M
Neurocrine Biosciences, Inc.(NBIX)0181,897+181,897$0$25.53M3.83%+$25.53M
ABIVAX Société AnonymeADS(ABVX)0291,820+291,820$0$24.78M3.72%+$24.78M
Newamsterdam Pharma Company
ORDINARY SHARES
521,097716,971+195,874$9.44M$20.39M3.06%+$10.95M
Akero Therapeutics Inc114,554397,010+282,456$6.11M$18.85M2.83%+$12.74M
Axsome Therapeutics, Inc.(AXSM)144,400152,614+8,214$15.07M$18.53M2.78%+$3.46M
Enliven Therapeutics Inc509,987783,411+273,424$10.23M$16.04M2.41%+$5.81M
Apogee Therapeutics Inc311,490402,811+91,321$13.53M$16.00M2.40%+$2.48M
Kymera Therapeutics, Inc.(KYMR)0277,726+277,726$0$15.72M2.36%+$15.72M
Janux Therapeutics, Inc.(JANX)447,420639,699+192,279$10.34M$15.63M2.35%+$5.30M
Roivant Sciences Ltd.SHS(ROIV)0959,703+959,703$0$14.52M2.18%+$14.52M
Cytokinetics, Incorporated(CYTK)0254,795+254,795$0$14.00M2.10%+$14.00M
Natera, Inc.(NTRA)118,13080,875-37,255$19.96M$13.02M1.95%-$6.94M
Adma Biologics Inc1,092,361808,673-283,688$19.89M$11.86M1.78%-$8.04M
Vera Therapeutics, Inc.CL A(VERA)309,666354,529+44,863$7.30M$10.30M1.55%+$3.01M
Harrow, Inc.(HROW)228,761160,234-68,527$6.99M$7.72M1.16%+$733.7K
MoonLake ImmunotherapeuticsCL A(MLTX)0262,643+262,643$0$1.88M0.28%+$1.88M
Alnylam Pharmaceuticals, Inc.(ALNY)17,8790-17,879$5.83M$0—-$5.83M
ARS Pharmaceuticals, Inc.(SPRY)455,9530-455,953$7.96M$0—-$7.96M
Beta Bionics, Inc.(BBNX)157,1940-157,194$2.29M$0—-$2.29M
Boston Scientific Corporation(BSX)138,8340-138,834$14.91M$0—-$14.91M
Guardant Health, Inc.(GH)302,3070-302,307$15.73M$0—-$15.73M
HealthEquity, Inc.(HQY)80,8800-80,880$8.47M$0—-$8.47M
Insulet Corporation(PODD)51,4080-51,408$16.15M$0—-$16.15M
Intuitive Surgical, Inc.(ISRG)32,3050-32,305$17.55M$0—-$17.55M
Kalvista Pharmaceuticals Inc214,1380-214,138$2.42M$0—-$2.42M
RadNet, Inc.(RDNT)197,7590-197,759$11.25M$0—-$11.25M
Soleno Therapeutics Inc86,3320-86,332$7.23M$0—-$7.23M
TG Therapeutics, Inc.(TGTX)447,8840-447,884$16.12M$0—-$16.12M
Verona Pharma PlcADS309,9880-309,988$29.32M$0—-$29.32M
Page 1 of 1
First Turn Management, LLC — 13F Holdings — Q3 2025 | TickerTrail